NexgenRx Announces Annual Meeting Results

TORONTO, ON / ACCESSWIRE / May 16, 2024 / NexgenRx Inc. shared outcomes from its annual and special meeting of shareholders on May 16, 2024. The meeting covered the presentation of annual financial statements, the appointment of directors and auditors, and approval of the Stock Option Plan. A total of 42,427,411 common shares were represented, about 59.8% of the total issued shares.

All proposed resolutions at the meeting were affirmed by the shareholders. Notably, Director Charles Burns faced a voting predicament where the number of votes "Withheld" surpassed those "For" his election. In accordance with the Company's Majority Voting Policy, Burns has offered his resignation. However, the board plans to temporarily withhold its acceptance until a suitable replacement is appointed, expected by September 30, 2024.